Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 311, Issue 5, 2016, Pages F877-F889

  Akchurin, Oleh ^a   Sureshbabu, Angara ^a   Doty, Steve B ^b   Zhu, Yuan Shan ^a   Patino, Edwin ^a   Cunningham Rundles, Susanna ^a   Choi, Mary E ^a   Boskey, Adele ^a,b   Rivella, Stefano ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenine; Anemia; Chronic kidney disease; Growth delay; Hepcidin

Indexed keywords

ADENINE; CREATININE; FIBROBLAST GROWTH FACTOR 23; GROWTH HORMONE; HEPCIDIN; INTERLEUKIN 6; IRON; PHOSPHORUS; SOMATOMEDIN C; TUMOR NECROSIS FACTOR;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GROWTH RATE; GROWTH RETARDATION; INFLAMMATION; IRON BLOOD LEVEL; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TRABECULAR BONE; UREA NITROGEN BLOOD LEVEL; UREMIA; WEANING; ANIMAL; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; DIAGNOSTIC IMAGING; DISEASE MODEL; EPIPHYSIS PLATE; FEMUR; GENETICS; GROWTH DISORDER; KNOCKOUT MOUSE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY;

ADENINE; ANEMIA; ANIMALS; DISEASE MODELS, ANIMAL; FEMUR; GROWTH DISORDERS; GROWTH PLATE; HEPCIDINS; MICE; MICE, KNOCKOUT; RENAL INSUFFICIENCY, CHRONIC; X-RAY MICROTOMOGRAPHY;

EID: 84994609041     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00089.2016     Document Type: Article

References (67)

1. Abraham AG, Mak RH, Mitsnefes M, White C, Moxey-Mims M, Warady B, Furth SL. Protein energy wasting in children with chronic kidney disease. Pediatr Nephrol 29: 1231-1238, 2014.
2. Aeberli I, Hurrell RF, Zimmermann MB. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes 33: 1111-1117, 2009.
3. Agarwal R. Proinflammatory effects of iron sucrose in chronic kidney disease. Kidney Int 69: 1259-1263, 2006.
4. Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 39: 84-92, 2015.
5. Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL. Medication adherence and growth in children with CKD. Clin J Am Soc Nephrol 9: 1519-1525, 2014.
6. Al-Uzri A, Matheson M, Gipson DS, Mendley SR, Hooper SR, Yadin O, Rozansky DJ, Moxey-Mims M, Furth SL, Warady BA, Gerson AC. The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr 163:736-741 e731, 2013.
7. Amato A, Santoro N, Calabro P, Grandone A, Swinkels DW, Perrone L, del Giudice EM. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes 34: 1772-1774, 2010.
8. Arnold WC, Danford D, Holliday MA. Effects of caloric supplementation on growth in children with uremia. Kidney Int 24: 205-209, 1983.
9. Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol 30: 635-643, 2015.
10. Ayestaran FW, Schneider MF, Kaskel FJ, Srivaths PR, Seo-Mayer PW, Moxey-Mims M, Furth SL, Warady BA, Greenbaum LA. Perceived appetite and clinical outcomes in children with chronic kidney disease. Pediatr Nephrol 31: 1121-1127, 2016.
11. Bamgbola OF. Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease. Kidney Int 80: 464-474, 2011.
12. Bendich A, Brown GB, Philips FS, Thiersch JB. The direct oxidation of adenine in vivo. J Biol Chem 183: 267-277, 1950.
13. Carvalho C, Isakova T, Collerone G, Olbina G, Wolf M, Westerman M, Gutierrez OM. Hepcidin and disordered mineral metabolism in chronic kidney disease. Clin Nephrol 76: 90-98, 2011.
14. Casimiro de Almeida J, Lou-Meda R, Olbert M, Seifert M, Weiss G, Wiegerinck ET, Swinkels DW, Solomons NW, Schumann K. The growth attainment, hematological, iron status and inflammatory profile of Guatemalan juvenile end-stage renal disease patients. PLoS One 10:e0140062, 2015.
15. Chantler C, Lieberman E, Holliday MA. A rat model for the study of growth failure in uremia. Pediatr Res 8: 109-113, 1974.
16. Cheung WW, Ding W, Gunta SS, Gu Y, Tabakman R, Klapper LN, Gertler A, Mak RH. A pegylated leptin antagonist ameliorates CKDassociated cachexia in mice. J Am Soc Nephrol 25: 119-128, 2014.
17. Claramunt D, Gil-Pena H, Fuente R, Garcia-Lopez E, Loredo V, Hernandez-Frias O, Ordonez FA, Rodriguez-Suarez J, Santos F. Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia. Am J Physiol Renal Physiol 309:F57-F62, 2015.
18. Cobo A, Carbajo E, Santos F, Garcia E, Lopez JM. Morphometry of uremic rat growth plate. Miner Electrolyte Metab 22: 192-195, 1996.
19. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28: 2-17, 2013.
20. Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci 152:244-248, 2016.
21. Farquharson C, Ahmed SF. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH/IGF-1 signaling. Pediatr Nephrol 28:547-556, 2013.
22. Fine RN, Kohaut EC, Brown D, Perlman AJ. Growth after recombinant human growth hormone treatment in children with chronic renal failure:report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 124: 374-382, 1994.
23. Gao Y, Li Z, Gabrielsen JS, Simcox JA, Lee SH, Jones D, Cooksey B, Stoddard G, Cefalu WT, McClain DA. Adipocyte iron regulates leptin and food intake. J Clin Invest 125: 3681-3691, 2015.
24. Gardenghi S, Renaud TM, Meloni A, Casu C, Crielaard BJ, Bystrom LM, Greenberg-Kushnir N, Sasu BJ, Cooke KS, Rivella S. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123: 1137-1145, 2014.
25. Hanna JD, Santos F, Foreman JW, Chan JC, Han VK. Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 47: 1374-1382, 1995.
26. Horl WH. Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol 9: 291-301, 2013.
27. Kikuchi H, Kanda E, Mandai S, Akazawa M, Iimori S, Oi K, Naito S, Noda Y, Toda T, Tamura T, Sasaki S, Sohara E, Okado T, Rai T, Uchida S. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKDROUTE) study. Clin Exp Nephrol 2016 Feb 26. [Epub ahead of print].
28. Kim A, Fung E, Parikh SG, Valore EV, Gabayan V, Nemeth E, Ganz T. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 123: 1129-1136, 2014.
29. Ku E, Fine RN, Hsu CY, McCulloch C, Glidden DV, Grimes B, Johansen KL. Height at first RRT and mortality in children. Clin J Am Soc Nephrol 11: 832-839, 2016.
30. Lane PH. Puberty and chronic kidney disease. Adv Chronic Kidney Dis 12: 372-377, 2005.
31. Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP. Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 25: 2088-2096, 2014.
32. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 64: 350-355, 2003.
33. Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 21: 917-930, 2006.
34. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med 350: 2654-2662, 2004.
35. Molinos I, Santos F, Carbajo-Perez E, Garcia E, Rodriguez J, Garcia-Alvarez O, Gil H, Ordonez FA, Loredo V, Mallada L. Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it. Kidney Int 70: 1955-1961, 2006.
36. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99: 4596-4601, 2002.
37. Oikonomidou PR, Casu C, Yang Z, Crielaard B, Shim JH, Rivella S, Vogiatzi MG. Polycythemia is associated with bone loss and reduced osteoblast activity in mice. Osteoporos Int 27: 1559-1568, 2016.
38. Padeh S, Pinhas-Hamiel O, Zimmermann-Sloutskis D, Berkun Y. Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation. J Pediatr 159: 832-837, e831-832, 2011.
39. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001.
40. Patel NM, Gutierrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77: 715-720, 2010.
41. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, Amodeo C, Cuppari L, Kamimura MA. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30: 1718-1725, 2015.
42. Philips FS, Thiersch JB, Bendich A. Adenine intoxication in relation to in vivo formation and deposition of 2,8-dioxyadenine in renal tubules. J Pharmacol Exp Ther 104: 20-30, 1952.
43. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993.
44. Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, Furth SL, Warady BA. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol 29: 1987-1995, 2014.
45. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23: 291-299, 2001.
46. Runolfsdottir HL, Palsson R, Agustsdottir IM, Indridason OS, Edvardsson VO. Kidney disease in adenine phosphoribosyltransferase deficiency. Am J Kidney Dis 67: 431-438, 2016.
47. Santana AC, Degaspari S, Catanozi S, Delle H, de Sa Lima L, Silva C, Blanco P, Solez K, Scavone C, Noronha IL. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. Nephrol Dial Transpl 28: 1140-1149, 2013.
48. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115: 3616-3624, 2010.
49. Schaefer F, Veldhuis JD, Stanhope R, Jones J, Scharer K. Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. Cooperative Study Group of Pubertal development in Chronic Renal Failure. J Clin Endocrinol Metab 78: 1298-1306, 1994.
50. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
51. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A. Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 18: 796-804, 2003.
52. Seikaly MG, Salhab N, Gipson D, Yiu V, Stablein D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatr Nephrol 21: 793-799, 2006.
53. Singh L, Brennan TA, Russell E, Kim JH, Chen Q, Brad Johnson F, Pignolo RJ. Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage. Bone 85: 29-36, 2016.
54. Sun CC, Vaja V, Babitt JL, Lin HY. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol 87: 392-400, 2012.
55. Sun CC, Vaja V, Chen S, Theurl I, Stepanek A, Brown DE, Cappellini MD, Weiss G, Hong CC, Lin HY, Babitt JL. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transpl 28: 1733-1743, 2013.
56. Taft RA, Davisson M, Wiles MV. Know thy mouse. Trends Genet 22:649-653, 2006.
57. Tamura M, Aizawa R, Hori M, Ozaki H. Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem Cell Biol 131: 483-490, 2009.
58. Tonshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 138: 938-946, 1997.
59. Troib A, Guterman M, Rabkin R, Landau D, Segev Y. Endurance exercise and growth hormone improve bone formation in young and growth-retarded chronic kidney disease rats. Nephrol Dial Transpl 31:1270-1279, 2015.
60. Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates. J Clin Lab Anal 27: 504-510, 2013.
61. Ulinski T, Mohan S, Kiepe D, Blum WF, Wingen AM, Mehls O, Tonshoff B. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 14: 589-597, 2000.
62. Waller SC, Ridout D, Cantor T, Rees L. Parathyroid hormone and growth in children with chronic renal failure. Kidney Int 67: 2338-2345, 2005.
63. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int 64: 572-578, 2003.
64. Wong H, Mylrea K, Feber J, Drukker A, Filler G. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70: 585-590, 2006.
65. Yokozawa T, Zheng PD, Oura H. Biochemical features induced by adenine feeding in rats. Polyuria, electrolyte disorders, and 2,8-dihydroxyadenine deposits. J Nutr Sci Vitaminol 30: 245-254, 1984.
66. Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 44: 230-234, 1986.
67. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 4: 1051-1056, 2009.